Related Experiment Video
Updated: Jan 6, 2026
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Identification of an E3 ligase-encoding gene RFWD3 in non-small cell lung cancer
Yanfei Zhang1,2,3, Xinchun Zhao4, Yongchun Zhou5
1State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.
Abstract:
In order to unveil ubiquitin pathway genes (UPGs) that are essential for non-small cell lung cancer (NSCLC) cell proliferation, we recently conducted a siRNA screening experiment to knockdown the expression of 696 UPGs found in the human genome in A549 and H1975 NSCLC cells. We found that silencing of one of the candidates, RFWD3 that encodes an E3 ubiquitin ligase essential for the repair of DNA interstrand cross-links in response to DNA damage, led to dramatic inhibition of NSCLC cell proliferation with significant Z-scores. Knockdown of RFWD3 suppressed colony forming activity of NSCLC cells.We further evaluated the significance of RFWD3 in NSCLCs and found that this gene was more elevated in tumor samples than in paired normal lung tissues and was inversely associated with the clinical outcome of patients with NSCLC. Moreover, RFWD3 expression was significantly higher in smokers than in non-smokers. These results show for the first time that RFWD3 is required for NSCLC cell proliferation and may have an important role in lung carcinogenesis.
Insights
Researchers identified RFWD3, an E3 ubiquitin ligase, as crucial for non-small cell lung cancer (NSCLC) cell growth. Silencing RFWD3 inhibited NSCLC proliferation and colony formation, suggesting its role in lung cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small cell lung cancer (NSCLC) proliferation is driven by complex genetic factors.
- Ubiquitin pathway genes (UPGs) play critical roles in cellular processes, including cancer development.
- Identifying key UPGs in NSCLC can reveal novel therapeutic targets.
Purpose of the Study:
- To identify essential ubiquitin pathway genes (UPGs) involved in non-small cell lung cancer (NSCLC) cell proliferation.
- To investigate the role of RFWD3, an E3 ubiquitin ligase, in NSCLC progression.
- To explore the correlation between RFWD3 expression and clinical outcomes in NSCLC patients.
Main Methods:
- Conducted a large-scale siRNA screening of 696 UPGs in A549 and H1975 NSCLC cell lines.
- Assessed the impact of UPG knockdown on NSCLC cell proliferation and colony formation.
- Analyzed RFWD3 expression levels in NSCLC tumor tissues versus normal lung tissues.
- Correlated RFWD3 expression with patient clinical outcomes and smoking status.
Main Results:
- Silencing of RFWD3 significantly inhibited NSCLC cell proliferation and colony-forming activity.
- RFWD3 expression was significantly elevated in NSCLC tumor samples compared to normal lung tissues.
- Higher RFWD3 expression was inversely associated with favorable clinical outcomes in NSCLC patients.
- RFWD3 levels were notably higher in smokers compared to non-smokers.
Conclusions:
- RFWD3 is essential for NSCLC cell proliferation and plays a significant role in lung carcinogenesis.
- RFWD3 represents a potential therapeutic target for NSCLC treatment.
- RFWD3 expression may serve as a prognostic biomarker in NSCLC, particularly in relation to smoking.
